How does the National Joint Registry's work benefit me? How can I become a part of the NJR's Regional Support network? Who are the working groups the NJR works with? We aim to answer all your questions whether it be in person at a conference, in our Annual Report and weekly reports or here on out website

NJR Board (NJRB)
key responsibilities

The key responsibilities of the NJR Board are to ensure that:

  • Appropriate advice is provided to the Healthcare Quality Improvement Partnership, (the legal entity which hosts the NJR on behalf of NHS England Medical Directorate), on operational and financial matters;
  • The NJR budget is effectively managed and monitored;
  • The NJR sub-committee structure is fit for purpose and that all sub-committees have clear terms of reference, agreed composition, and defined purpose and responsibilities and report outcomes to the NJR Board regularly;
  • Outcomes achieved by brand of prostheses, hospital and surgeon are monitored and where these fall below expected performance, are highlighted to enable prompt investigation and follow-up by relevant implant suppliers, regulators, commissioners and providers of orthopaedic care;
  • Appropriate stakeholders (patients, clinicians, providers and commissioners of healthcare, regulators, professional societies and implant suppliers) are involved in and consulted on the work of the NJR as appropriate and informed of outcomes achieved in joint replacement surgery;
  • Patient awareness of joint replacement outcomes is enhanced to better inform patient choice and quality of experience, through engagement with patients, patient organisations and providers of care;
  • Evidence-based purchasing (quality and value for money) of joint replacement implants by healthcare providers is supported;
  • Post-market surveillance of implants by key stakeholders (implant suppliers, the Medicines and Healthcare products Regulatory Agency, Beyond Compliance and Orthopaedic Devices Evaluation Panel) is supported;
  • Codes of conduct applied to NJR contractor(s) in their relationship with key stakeholders are monitored;
  • Delivery and quality of work of NJR contractors is effectively contract managed;
  • Accurate, relevant and timely data collected by the NJR, is made available to relevant regulators, commissioners and providers/suppliers of orthopaedic care, in an appropriate format, in order to support clinical governance and patient safety;
  • An annual report on the work of the NJR is published and made available in both the English and Welsh languages and in a patient-friendly online format:
  • Appropriate governance and monitoring arrangements are in place to facilitate the use of NJR data to support and enable related research;
  • NHS England (and devolved administrations as appropriate) is provided with advice on the NJR’s strategic direction, annual work programme and financial position (including annual review of subscription charges and any proposed change);
  • NHS England is updated on the performance of prostheses and good surgical practice, international collaboration work with other national orthopaedic joint registries, and any financial and/or intellectual property implications associated with the licensing of the ‘NJR brand’.
Scroll to Top